{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:17:36Z","timestamp":1785889056431,"version":"3.56.0"},"reference-count":59,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004326","name":"Bayer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007659","name":"Bayer Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","bbmt.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.bbmt.2019.05.030","type":"journal-article","created":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T10:33:40Z","timestamp":1559385220000},"page":"1475-1485","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Long-Acting IL-33 Mobilizes High-Quality Hematopoietic Stem and Progenitor Cells More Efficiently Than Granulocyte Colony-Stimulating Factor or AMD3100"],"prefix":"10.1016","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5506-7534","authenticated-orcid":false,"given":"Carsten","family":"Alt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shujun","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faye","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basha","family":"Stankovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joy","family":"Calaoagan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Schopies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josephine Y.","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doug","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Yan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaun M.","family":"Lippow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxine","family":"Bauzon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"17","key":"10.1016\/j.bbmt.2019.05.030_bib0001","doi-asserted-by":"crossref","first-page":"4530","DOI":"10.1182\/blood-2011-06-318220","article-title":"How I treat patients who mobilize hematopoietic stem cells poorly","volume":"118","author":"To","year":"2011","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.bbmt.2019.05.030_bib0002","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.transci.2017.11.017","article-title":"Management of mobilization failure in 2017","volume":"56","author":"Namdaroglu","year":"2017","journal-title":"Transfus Apher Sci"},{"issue":"1","key":"10.1016\/j.bbmt.2019.05.030_bib0003","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.blre.2014.01.001","article-title":"Advances in stem cell mobilization","volume":"28","author":"Hopman","year":"2014","journal-title":"Blood Rev"},{"issue":"5","key":"10.1016\/j.bbmt.2019.05.030_bib0004","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1111\/trf.12979","article-title":"Evaluation of Dutch guideline for just-in-time addition of plerixafor to stem cell mobilization in patients who fail with granulocyte-colony-stimulating factor","volume":"55","author":"Bilgin","year":"2015","journal-title":"Transfusion (Paris)"},{"key":"10.1016\/j.bbmt.2019.05.030_bib0005","doi-asserted-by":"crossref","DOI":"10.1177\/2040206619829382","article-title":"Mozobil\u00ae (Plerixafor, AMD3100), 10 years after its approval by the US Food and Drug Administration","volume":"27","author":"De Clercq","year":"2019","journal-title":"Antivir Chem Chemother"},{"issue":"7","key":"10.1016\/j.bbmt.2019.05.030_bib0006","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/bmt.2015.58","article-title":"Leukemia cell mobilization with G-CSF plus plerixafor during busulfan\u2014fludarabine conditioning for allogeneic stem cell transplantation","volume":"50","author":"Konopleva","year":"2015","journal-title":"Bone Marrow Transplant"},{"issue":"5","key":"10.1016\/j.bbmt.2019.05.030_bib0007","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.immuni.2005.09.015","article-title":"IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines","volume":"23","author":"Schmitz","year":"2005","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.bbmt.2019.05.030_bib0008","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/ni.3370","article-title":"Interleukin 33 is a guardian of barriers and a local alarmin","volume":"17","author":"Martin","year":"2016","journal-title":"Nat Immunol"},{"issue":"10","key":"10.1016\/j.bbmt.2019.05.030_bib0009","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/nrd2660","article-title":"The IL-33\/ST2 pathway: therapeutic target and novel biomarker","volume":"7","author":"Kakkar","year":"2008","journal-title":"Nat Rev Drug Discov"},{"issue":"10","key":"10.1016\/j.bbmt.2019.05.030_bib0010","first-page":"1398","article-title":"Structure of IL-33 and its interaction with the ST2 and IL-1RAcP receptors\u2014insight into heterotrimeric IL-1 signaling complexes","volume":"17","author":"Lingel","year":"2009","journal-title":"Struct Lond Engl 1993"},{"issue":"37","key":"10.1016\/j.bbmt.2019.05.030_bib0011","doi-asserted-by":"crossref","first-page":"14918","DOI":"10.1073\/pnas.1308651110","article-title":"Structural insights into the interaction of IL-33 with its receptors","volume":"110","author":"Liu","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.bbmt.2019.05.030_bib0012","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.immuni.2009.05.007","article-title":"Suppression of interleukin-33 bioactivity through proteolysis by apoptotic caspases","volume":"31","author":"L\u00fcthi","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.bbmt.2019.05.030_bib0013","doi-asserted-by":"crossref","first-page":"8327","DOI":"10.1038\/ncomms9327","article-title":"Oxidation of the alarmin IL-33 regulates ST2-dependent inflammation","volume":"6","author":"Cohen","year":"2015","journal-title":"Nat Commun"},{"issue":"10","key":"10.1016\/j.bbmt.2019.05.030_bib0014","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1038\/labinvest.3700663","article-title":"IL-33 can promote survival, adhesion and cytokine production in human mast cells","volume":"87","author":"Iikura","year":"2007","journal-title":"Lab Investig J Tech Methods Pathol"},{"issue":"5","key":"10.1016\/j.bbmt.2019.05.030_bib0015","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.clinthera.2016.02.021","article-title":"Potential therapeutic aspects of alarmin cytokine interleukin 33 or its inhibitors in various diseases","volume":"38","author":"Arshad","year":"2016","journal-title":"Clin Ther"},{"issue":"19","key":"10.1016\/j.bbmt.2019.05.030_bib0016","doi-asserted-by":"crossref","first-page":"E2705","DOI":"10.1073\/pnas.1604032113","article-title":"IL-33 ameliorates Alzheimer's disease-like pathology and cognitive decline","volume":"113","author":"Fu","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7","key":"10.1016\/j.bbmt.2019.05.030_bib0017","doi-asserted-by":"crossref","first-page":"3792","DOI":"10.4049\/jimmunol.1400176","article-title":"IL-33-induced hematopoietic stem and progenitor cell mobilization depends upon CCR2","volume":"193","author":"Kim","year":"2014","journal-title":"J Immunol"},{"issue":"13","key":"10.1016\/j.bbmt.2019.05.030_bib0018","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera\u2014a visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J Comput Chem"},{"issue":"6","key":"10.1016\/j.bbmt.2019.05.030_bib0019","doi-asserted-by":"crossref","first-page":"639","DOI":"10.2174\/157016209789973682","article-title":"Increased CCL2 expression and macrophage\/monocyte migration during microbicide-induced vaginal irritation","volume":"7","author":"Alt","year":"2009","journal-title":"Curr HIV Res"},{"issue":"43","key":"10.1016\/j.bbmt.2019.05.030_bib0020","doi-asserted-by":"crossref","first-page":"15502","DOI":"10.1073\/pnas.1410700111","article-title":"Central domain of IL-33 is cleaved by mast cell proteases for potent activation of group-2 innate lymphoid cells","volume":"111","author":"Lefran\u00e7ais","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.bbmt.2019.05.030_bib0021","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1161\/ATVBAHA.112.253427","article-title":"Interleukin-33 drives a proinflammatory endothelial activation that selectively targets nonquiescent cells","volume":"33","author":"Pollheimer","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"10","key":"10.1016\/j.bbmt.2019.05.030_bib0022","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/S0169-409X(03)00108-X","article-title":"Pharmacokinetic and biodistribution properties of poly(ethylene glycol)-protein conjugates","volume":"55","author":"Caliceti","year":"2003","journal-title":"Adv Drug Deliv Rev"},{"issue":"12","key":"10.1016\/j.bbmt.2019.05.030_bib0023","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1038\/nbt.1588","article-title":"A recombinant polypeptide extends the in vivo half-life of peptides and proteins in a tunable manner","volume":"27","author":"Schellenberger","year":"2009","journal-title":"Nat Biotechnol"},{"issue":"4","key":"10.1016\/j.bbmt.2019.05.030_bib0024","first-page":"215","article-title":"Fusion proteins for half-life extension of biologics as a strategy to make biobetters","volume":"29","author":"Strohl","year":"2015","journal-title":"Biodrugs Clin Immunother Biopharm Gene Ther"},{"issue":"7","key":"10.1016\/j.bbmt.2019.05.030_bib0025","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1093\/protein\/9.7.617","article-title":"\u201cKnobs-into-holes\u201d engineering of antibody CH3 domains for heavy chain heterodimerization","volume":"9","author":"Ridgway","year":"1996","journal-title":"Protein Eng"},{"issue":"3","key":"10.1016\/j.bbmt.2019.05.030_bib0026","first-page":"151","article-title":"Monomeric Fc fusions: impact on pharmacokinetic and biological activity of protein therapeutics","volume":"20","author":"Dumont","year":"2006","journal-title":"Biodrugs Clin Immunother Biopharm Gene Ther"},{"issue":"1","key":"10.1016\/j.bbmt.2019.05.030_bib0027","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1073\/pnas.0606854104","article-title":"IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo","volume":"104","author":"Carriere","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.1016\/j.bbmt.2019.05.030_bib0028","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.4049\/jimmunol.1003080","article-title":"The dual function cytokine IL-33 interacts with the transcription factor NF-\u03baB to dampen NF-\u03baB-stimulated gene transcription","volume":"187","author":"Ali","year":"2011","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.bbmt.2019.05.030_bib0029","doi-asserted-by":"crossref","first-page":"3363","DOI":"10.1038\/s41598-018-21589-2","article-title":"Interleukin-33 is activated by allergen- and necrosis-associated proteolytic activities to regulate its alarmin activity during epithelial damage","volume":"8","author":"Scott","year":"2018","journal-title":"Sci Rep"},{"issue":"22","key":"10.1016\/j.bbmt.2019.05.030_bib0030","doi-asserted-by":"crossref","first-page":"20078","DOI":"10.1074\/jbc.M111.219089","article-title":"Identification of constitutively active interleukin 33 (IL-33) splice variant","volume":"286","author":"Hong","year":"2011","journal-title":"J Biol Chem"},{"issue":"11","key":"10.1016\/j.bbmt.2019.05.030_bib0031","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1038\/jid.2012.180","article-title":"Novel splice variants of IL-33: differential expression in normal and transformed cells","volume":"132","author":"Tsuda","year":"2012","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.bbmt.2019.05.030_bib0032","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/8459402","article-title":"Redox regulation of inflammatory processes is enzymatically controlled","volume":"2017","author":"Lorenzen","year":"2017","journal-title":"Oxid Med Cell Longev"},{"issue":"6","key":"10.1016\/j.bbmt.2019.05.030_bib0033","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.smim.2013.10.023","article-title":"The interleukin-1 receptor family","volume":"25","author":"Boraschi","year":"2013","journal-title":"Semin Immunol"},{"issue":"3","key":"10.1016\/j.bbmt.2019.05.030_bib0034","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1182\/blood-2005-05-2140","article-title":"SLAM family markers are conserved among hematopoietic stem cells from old and reconstituted mice and markedly increase their purity","volume":"107","author":"Yilmaz","year":"2006","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.bbmt.2019.05.030_bib0035","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1182\/blood-2008-10-184721","article-title":"BIO5192, a small molecule inhibitor of VLA-4, mobilizes hematopoietic stem and progenitor cells","volume":"114","author":"Ramirez","year":"2009","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.bbmt.2019.05.030_bib0036","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1182\/blood-2011-06-358614","article-title":"S1P promotes murine progenitor cell egress and mobilization via S1P1-mediated ROS signaling and SDF-1 release","volume":"119","author":"Golan","year":"2012","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.bbmt.2019.05.030_bib0037","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1182\/blood.V75.3.563.563","article-title":"A comparison of hematopoiesis in normal and splenectomized mice treated with granulocyte colony-stimulating factor","volume":"75","author":"Molineux","year":"1990","journal-title":"Blood"},{"issue":"5272","key":"10.1016\/j.bbmt.2019.05.030_bib0038","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1126\/science.273.5272.242","article-title":"Long-term lymphohematopoietic reconstitution by a single CD34-low\/negative hematopoietic stem cell","volume":"273","author":"Osawa","year":"1996","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.bbmt.2019.05.030_bib0039","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1182\/blood.V94.8.2548.420k38_2548_2554","article-title":"Reversible expression of CD34 by murine hematopoietic stem cells","volume":"94","author":"Sato","year":"1999","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.bbmt.2019.05.030_bib0040","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1182\/blood.V96.5.1989","article-title":"CD34 expression by murine hematopoietic stem cells mobilized by granulocyte colony-stimulating factor","volume":"96","author":"Tajima","year":"2000","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.bbmt.2019.05.030_bib0041","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/nri3062","article-title":"Inflammatory modulation of HSCs: viewing the HSC as a foundation for the immune response","volume":"11","author":"King","year":"2011","journal-title":"Nat Rev Immunol"},{"issue":"11","key":"10.1016\/j.bbmt.2019.05.030_bib0042","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1038\/bmt.2011.240","article-title":"Is it time to revisit our current hematopoietic progenitor cell quantification methods in the clinic?","volume":"47","author":"Beksac","year":"2012","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"10.1016\/j.bbmt.2019.05.030_bib0043","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s10238-004-0041-4","article-title":"Timely reconstitution of immune competence affects clinical outcome following autologous stem cell transplantation","volume":"4","author":"Porrata","year":"2004","journal-title":"Clin Exp Med"},{"issue":"5","key":"10.1016\/j.bbmt.2019.05.030_bib0044","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0092-8674(00)80453-5","article-title":"Identification of clonogenic common lymphoid progenitors in mouse bone marrow","volume":"91","author":"Kondo","year":"1997","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.bbmt.2019.05.030_bib0045","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/cyto.a.20674","article-title":"Mouse hematopoietic stem cell identification and analysis","volume":"75","author":"Challen","year":"2009","journal-title":"Cytom Part J Int Soc Anal Cytol"},{"issue":"1","key":"10.1016\/j.bbmt.2019.05.030_bib0046","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1084\/jem.20170449","article-title":"IL-33 promotes the egress of group 2 innate lymphoid cells from the bone marrow","volume":"215","author":"Stier","year":"2018","journal-title":"J Exp Med"},{"issue":"14","key":"10.1016\/j.bbmt.2019.05.030_bib0047","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1182\/blood-2009-02-203372","article-title":"Interleukin-33 induces angiogenesis and vascular permeability through ST2\/TRAF6-mediated endothelial nitric oxide production","volume":"114","author":"Choi","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2019.05.030_bib0048","doi-asserted-by":"crossref","unstructured":"Pfeiler S, Winkels H, Kelm M, Gerdes N.IL-1 family cytokines in cardiovascular disease [epub ahead of print]. Cytokine. doi:10.1016\/j.cyto.2017.11.009, accessed 07\/11\/2018.","DOI":"10.1016\/j.cyto.2017.11.009"},{"key":"10.1016\/j.bbmt.2019.05.030_bib0049","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.brainres.2015.02.010","article-title":"Endothelial progenitor cells and revascularization following stroke","volume":"1623","author":"Ma","year":"2015","journal-title":"Brain Res"},{"key":"10.1016\/j.bbmt.2019.05.030_bib0050","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1177\/0963689718779345","article-title":"Endothelial progenitor cells in age-related vascular remodeling","volume":"27","author":"Yang","year":"2018","journal-title":"Cell Transplant"},{"issue":"4","key":"10.1016\/j.bbmt.2019.05.030_bib0051","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.cytogfr.2014.07.011","article-title":"G-CSF: from granulopoietic stimulant to bone marrow stem cell mobilizing agent","volume":"25","author":"Bendall","year":"2014","journal-title":"Cytokine Growth Factor Rev"},{"issue":"2","key":"10.1016\/j.bbmt.2019.05.030_bib0052","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.jaci.2008.10.022","article-title":"CD34+ hemopoietic progenitor cells are potent effectors of allergic inflammation","volume":"123","author":"Allakhverdi","year":"2009","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.bbmt.2019.05.030_bib0053","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1038\/s41598-018-38408-3","article-title":"IL1RL1 is dynamically expressed on Cbfb-MYH11+ leukemia stem cells and promotes cell survival","volume":"9","author":"Wang","year":"2019","journal-title":"Sci Rep"},{"issue":"22","key":"10.1016\/j.bbmt.2019.05.030_bib0054","doi-asserted-by":"crossref","first-page":"3404","DOI":"10.1182\/bloodadvances.2018020222","article-title":"Clinical consequences of clonal hematopoiesis of indeterminate potential","volume":"2","author":"Steensma","year":"2018","journal-title":"Blood Adv"},{"issue":"11","key":"10.1016\/j.bbmt.2019.05.030_bib0055","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1016\/j.bbmt.2016.08.002","article-title":"Identifying inherited and acquired genetic factors involved in poor stem cell mobilization and donor-derived malignancy","volume":"22","author":"Rojek","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.05.030_bib0056","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1196\/annals.1392.013","article-title":"AMD3100 and CD26 modulate mobilization, engraftment, and survival of hematopoietic stem and progenitor cells mediated by the SDF-1\/CXCL12-CXCR4 axis","volume":"1106","author":"Broxmeyer","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.bbmt.2019.05.030_bib0057","first-page":"49","article-title":"Hematopoietic stem cell mobilization with agents other than G-CSF","volume":"904","author":"Hoggatt","year":"2012","journal-title":"Methods Mol Biol"},{"issue":"9","key":"10.1016\/j.bbmt.2019.05.030_bib0058","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1038\/bmt.2011.170","article-title":"Novel agents and approaches for stem cell mobilization in normal donors and patients","volume":"47","author":"Bakanay","year":"2012","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"10.1016\/j.bbmt.2019.05.030_bib0059","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s12185-016-2156-2","article-title":"New agents in HSC mobilization","volume":"105","author":"Domingues","year":"2017","journal-title":"Int J Hematol"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879119303556?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879119303556?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T15:41:42Z","timestamp":1737992502000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879119303556"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":59,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["S1083879119303556"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2019.05.030","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.735908176.793568503","asserted-by":"object"}]},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-Acting IL-33 Mobilizes High-Quality Hematopoietic Stem and Progenitor Cells More Efficiently Than Granulocyte Colony-Stimulating Factor or AMD3100","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2019.05.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 American Society for Blood and Marrow Transplantation.","name":"copyright","label":"Copyright"}]}}